Table 2.
Diabetes characteristics of sample (n = 1,329)
| n/mean | %/SD | |
|---|---|---|
| Duration of diabetes (years) |
9.6 |
7.0 |
| HbA1c (among those providing a number; n = 393) |
7.25% |
1.5% |
| HbA1c in ranges |
|
|
| Up to 6.5% |
219 |
16.5% |
| 6.6%-7.0% |
214 |
16.1% |
| 7.1%-7.5% |
152 |
11.4% |
| 7.6%-8.5% |
146 |
11.0% |
| 8.6%-9.5% |
79 |
5.9% |
| 9.6%-10.5% |
44 |
3.3% |
| 10.6% or above |
34 |
2.6% |
| Unknown |
441 |
33.2% |
| Medications |
|
|
| Oral (OAD) only |
971 |
73.1% |
| Non-insulin injectable (NII) only |
16 |
1.2% |
| Insulin (IN) only |
79 |
5.9% |
| OAD & NII |
41 |
3.1% |
| OAD & IN |
174 |
13.1% |
| NII & IN |
7 |
0.5% |
| OAD, NII, & IN |
41 |
3.1% |
| Complications |
|
|
| Macular edema/diabetic retinopathy |
117 |
8.8% |
| Kidney disease |
51 |
3.8% |
| Foot or leg ulcer |
60 |
4.5% |
| Neuropathic pain |
220 |
16.6% |
| End organ damage |
18 |
1.4% |
| None | 989 | 74.4% |